Supported by DRISHTI CPS under the PRAYAS scheme, SkinMinds Derma Private Limited is making remarkable progress in the dermatological care sector with its innovative Facial Image Analyzer (FIA). This technology addresses a critical issue in India’s healthcare ecosystem: the lack of accessible, scientific dermatological solutions and the severely low ratio of dermatologists to the population. The traditional dermatological consultations rely on physical appointments with specialists, making them time-consuming and often inaccessible for widespread skincare needs.
FIA is a comprehensive solution for diagnosing various skin conditions through the analysis of multiple parameters captured through imaging technology. It is an AI-powered platform that integrates IoT devices with advanced analytical capabilities and a user-friendly interface, making it a stress-free solution for users to conduct skin health assessments remotely. SkinMinds utilizes artificial intelligence and data analytics to streamline the diagnostic process and optimize care recommendations. This innovative approach helps their users reduce consultation time, achieving faster results through personalized reports, and optimize their skincare routines through continuous AI-powered support.
By creating an ecosystem of personalized dermatology care in India, SkinMinds is completely transforming the current healthcare landscape, focusing on bringing advanced skin analysis and care recommendations to areas previously underserved by modern dermatological infrastructure. With DRISHTI CPS’ support, SkinMinds’ technology has been gaining strong customer acceptance in its commercial phase. The platform has been validated through numerous camps conducted across housing societies in Mumbai, creating awareness and making personalized skin care more accessible to the public.
SkinMinds’ commitment to innovation is evidenced by its three filed device patents for skin care technologies. The company has been recognized as the Best Skincare Screening Innovation of the Year 2023 by “Language of Diabetes” international. Their approach has been presented at prestigious forums like NASSCOM and discussed as a business case study in a guest lecture at a prestigious MBA college. The company is also collaborating with healthcare providers, dermatologists, and salons, enhancing their personalized skincare solutions and offering these professionals advanced tools for improved skincare care.
Why we invested in SkinMinds: We believe SkinMinds has the potential to redefine dermatological care delivery in India and serve as a model for similar challenges globally, making it a compelling investment that promises both significant impact and sustainable growth. What sets them apart is their exceptional team, combining expertise in AI, medical imaging, and healthcare – a technical backbone that enables them to deliver sophisticated dermatology solutions in user-friendly way. With India’s growing demand for skin health services, particularly as changing climate, weather patterns, and evolving food preferences contribute to the rising prevalence of skin problems across the country and worldwide, SkinMinds’ innovative platform is well-positioned to bridge a critical healthcare gap. We are confident that their unique combination of technical excellence and healthcare insight will not only transform dermatological care in India but also create significant value for all stakeholders in addressing one of the most pressing health challenges of our time.